Prostate cancer is one of the most common causes of cancer-related mortality in America and many other Western countries. It is usually diagnosed after a man reaches 60 or 70 years of age, allowing for greater chances of prevention or slowing down its progression.
According to reports, 50 percent of prostate cancer patients develop metastatic prostate carcinoma because they haven’t had the chance to avail of effective treatment plans, which include surgical resection, radiotherapy, or chemotherapy for localized tumor. For metastatic prostate cancer patients, it is recommended that they undergo androgen ablation because it can induce cell cycle arrest and apoptotic cell death in prostate cancer cells.
Most of these treatments only bring positive effects during the early stages of the cancer; during the advanced stages of the disease, the treatment methods ultimately fail and the patients die.
For more stories on new scientific studies and breakthroughs, visit Science.news.
Sources include:
Study: Ashwagandha extract can be used to improve sleep quality and relieve stress
By Michael Alexander // Share
What are some of the health benefits of quassia wood?
By Evangelyn Rodriguez // Share
Images from ESA’s spacecraft shows Nirgal Vallis, an ancient, dried-up river system on Mars
By Michael Alexander // Share
Evaluating the cytotoxicity of plant-derived phenolic compounds toward human carcinoma cells
By Evangelyn Rodriguez // Share
Researchers evaluate the antidiabetic activity of Mentha arvensis (wild mint)
By Evangelyn Rodriguez // Share
Handle with care: Why you need to wash fruits and veggies
By Rose Lidell // Share
Report: U.S. spent over $34 billion backing Israel in post-Oct. 7 wars, fueling Gaza genocide
By kevinhughes // Share
Federal shutdown sparks travel chaos as holiday season looms
By bellecarter // Share
Vatican's top diplomat condemns Israel's "ongoing massacre" in Gaza
By zoeysky // Share